No effect of spironolactone on bulimia nervosa symptoms.
von Wietersheim
Jörn
J
Müler-Bock
Vera
V
Rauh
Stephan
S
Danner
Bettina
B
Chrenko
Karin
K
Bühler
Georg
G
D000328:Adult; D052018:Bulimia Nervosa / Q000188:drug therapy* / Q000473:pathology; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D008901:Mineralocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*; D017211:Treatment Failure
D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids; D013148:Spironolactone